Vitamin B6 deficiency in uremia

Abstract

Significant decreases in plasma pyridoxal-5-phosphate (PLP), plasma glutamic-oxaloacetic transaminase (PGOT) and erythrocyte glutamic-oxaloacetic transaminase (EGOT) were found in 29 uremic patients including 14 who had been on hemodialysis an average of 15.8 months. The mean PLP values of the uremic patients (5.39 ± 0.37 ng/ml) were clearly lower than the values obtained for the normal group (9.30 ± 0.80 mg/ml). The mean PGOT values of the uremic patients (dialyzed 4.07 ± 0.29 U/liter, undialyzed 5.31 ± 0.49 U/liter) were significantly lower than the normal group (6.57 ± 0.39 U/liter). The mean EGOT value of the uremic patients (325 ± 17 U/liter) was also lower than normal subjects (416 ± 21 U/liter). Stimulation of the EGOT by exogenous PLP (EGOT index) was less in dialyzed patients (1.60) than normal subjects (1.80) while the undialyzed uremic subjects had a greater than normal stimulation (2.12). All of these results indicate that uremic patients are vitamin B₆ deficient and that those undergoing hemodialysis may have decreased amounts of the EGOT apoenzyme.